Sixteen patients with TB-HIV co-infection received rifabutin 300mg QD in combination with tuberculosis chemotherapy ( initially pyrazinamide , isoniazid and ethambutol then only isoniazid ) , and were then randomized to receive isoniazid and LPV/r based ART with rifabutin 150mg tiw or rifabutin 150mg daily .